drugset / Trial / NCT03377478
Expanding the Pool in Lung Transplantation
NaSingle-groupOpen-labelTreatment
Summary
To perform a study (20 patients) utilizing Hepatitis C positive (HCV Ab+/NAT -) donor lungs for hepatitis C negative recipients with post-operative surveillance and treatment only if a recipient infection occurs.
Timeline
- Start
- 2019-07-30
- Primary completion
- 2021-09-21
- Completion
- 2022-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | glecaprevir | Other / unclassified | — | — |